Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2014
12/10/2014CN103265617B 月桂酰氨基酰脯氨酸甲酯作为新型化学促透剂的制备方法及应用 Lauryl amido acid proline methyl ester as a new chemical penetration enhancers to promote preparation and application
12/10/2014CN103012550B 一种制备n(2)-l-丙氨酰-l-谷氨酰胺的方法 A process for preparing n (2) -l- alanyl -l- glutamine method
12/10/2014CN102827248B 一种具有抗日本脑炎病毒感染的三肽及其应用 An anti-Japanese encephalitis virus infection and its application tripeptide
12/10/2014CN102532262B 脂肪酸-rgd-脂肪醇偶联物介导表阿霉素靶向脂质体制备及抗肿瘤活性评价 -rgd- Fatty alcohols conjugates mediated targeting of epirubicin liposomes and antitumor activity evaluation
12/10/2014CN102477067B 3-氨基-2-羟基-4-苯基-缬氨酰-异亮氨酸及其制备方法和应用 3-amino-2-hydroxy-4-phenyl - valyl - isoleucine and its preparation method and application
12/10/2014CN102286070B 用于抑制蛋白酶体的化合物 Compounds for inhibiting the proteasome
12/09/2014US8907058 PSMA binding ligand-linker conjugates and methods for using
12/09/2014US8906861 Pharmaceutical compositions comprising cyclosporins
12/09/2014US8906859 Uses of kappa opioid synthetic peptide amides
12/09/2014US8906376 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/04/2014US20140357579 Synthetic peptide amides and dimers thereof
12/04/2014US20140357551 Organic compounds and their uses
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140356319 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
12/02/2014US8901276 Peptide reagents and methods for detection of colon dysplasia
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901072 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
11/2014
11/27/2014US20140350217 Functional lipid constructs
11/27/2014US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/27/2014US20140349942 Methods for reducing oxidative damage
11/27/2014US20140349941 Aromatic-cationic peptides and uses of same
11/27/2014US20140349921 Hcv ns3 protease inhibitors
11/27/2014US20140349920 N-acylpeptide derivatives and their uses
11/27/2014US20140349918 Derivatives of xanthone compounds
11/27/2014US20140349340 Mbth-like proteins in the production of semi synthetic antibiotics
11/27/2014US20140348919 Antibiotic compounds
11/27/2014US20140348864 Porcine circovirus type-2 (pcv2) subunit vaccine
11/27/2014US20140348804 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
11/25/2014US8895739 Acylation of hindered amines and functionalized bis-peptides obtained thereby
11/25/2014US8895698 Binding partners of antibodies specific for dendritic cell antigens
11/25/2014US8895696 Methods for forming peptides and peptide conjugates and peptides and peptide conjugates compositions formed thereby
11/25/2014US8895515 Cosmetic composition for skin cell regeneration mimicking extracellular matrix
11/25/2014US8895251 Method for detecting human BPLP protein or a maturation product thereof
11/25/2014US8895007 Antibodies which bind to the human CC chemokine receptor 4 and uses thereof
11/25/2014US8894971 Iodine radiolabelling method
11/20/2014US20140342997 Complex-forming compounds
11/20/2014US20140342991 Composition for improving brain function and method for improving brain function
11/20/2014US20140342989 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
11/20/2014US20140342977 Compounds for proteasome enzyme inhibition
11/20/2014US20140342399 Microorganism and method for overproduction of gamma-glutamylcysteine and derivatives of this dipeptide by fermentation
11/20/2014US20140341804 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
11/18/2014US8889880 Processes for preparing tubulysins
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889828 Conformations of divergent peptides with mineral binding affinity
11/18/2014US8889826 Peptide antibiotics and methods for making same
11/18/2014US8889634 Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
11/18/2014US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)
11/13/2014US20140336134 IAP BIR Domain Binding Compounds
11/13/2014US20140336132 Romidepsin solid forms and uses thereof
11/13/2014US20140336120 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury
11/13/2014US20140336115 Compounds, Compositions and Methods for the Treatment of Diseases Through Inhibiting TGF-ß Activity
11/13/2014US20140336109 Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
11/13/2014US20140336108 Compounds as tyrosine kinase modulators
11/13/2014US20140336106 Tripeptide epoxy ketone protease inhibitors
11/13/2014US20140335550 Fluorescent substrates for determining lysine modifying enzyme activity
11/11/2014US8884214 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
11/11/2014US8884057 Non-crystalline oxidized glutathione and production method therefor
11/11/2014US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883742 Peptide increasing fusiogenic capacity of a gamete
11/11/2014US8883734 Proteasome-activating anti-aging peptides and compositions containing same
11/11/2014US8883161 Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant
11/06/2014US20140329746 Methods and compositions for treating amyloid-related diseases
11/06/2014US20140329743 Method of Treating Melanocortin-4 Receptor-Associated Disorders in Heterozygous Carriers
11/06/2014US20140328796 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/04/2014US8877891 Method of producing a novel opioid peptide
11/04/2014US8877777 Process for purifying cyclolipopeptide compounds or the salts thereof
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877713 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/04/2014US8877707 Inhibitors of HCV NS5A
10/2014
10/30/2014US20140323394 Tripeptide kdpt for antiapoptotic treatment
10/30/2014US20140323390 Compounds and compositions as tlr2 agonists
10/28/2014US8871904 Processes and intermediates
10/28/2014US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
10/28/2014US8871720 Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
10/23/2014US20140315831 Synthesis of Libraries of Peptide Tertiary Amides
10/23/2014US20140315812 Amorphous ezatiostat ansolvate
10/23/2014US20140315801 Methods of treatment of cell proliferative and/or ophthalmic diseases, disorders and conditions using inhibitors of protein tyrosine kinase activity
10/23/2014US20140315796 Modulators of protease activated receptors
10/23/2014US20140315794 Antiparisitic dihydroazole compounds and compositions comprising same
10/23/2014US20140315792 Anti-viral compounds
10/23/2014US20140315790 Aminothiazoles and their uses
10/23/2014US20140315787 Antioxidant, Anti-Inflammatory, Anti-Radiation, Metal Chelating Compounds And Uses Thereof
10/23/2014US20140315783 Pyrimidine diol amides as sodium channel blockers
10/23/2014US20140314858 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same
10/23/2014US20140314669 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
10/21/2014US8865865 N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
10/21/2014US8865863 MCR dendrimers
10/21/2014US8865655 Depsipeptides and their therapeutic use
10/21/2014US8865654 Eye drops
10/16/2014US20140309401 Dpp-4 inhibitor
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140309162 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated, and use thereof
10/16/2014US20140308342 Reprogramming urokinase into an antibody-recruiting anticancer agent
10/14/2014US8859733 Compositions and methods for promoting wound healing and tissue regeneration
10/14/2014US8859730 Native chemical ligation at serine and threonine sites
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859725 Healthy kidney biomarkers
10/14/2014US8859723 Peptidomimetic macrocycles
10/14/2014US8859505 Cysteine protease inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 307